Degradation products of dabigatran etexilate salts
ZONG Xin-Jie;LI Chuan;FU Xiao-li;ZHANG Hai-zhi;LIU Chang-ying;LIU Peng;XU Wei-ren;Tianjin University of Traditional Chinese Medicine;Tianjin Key Laboratory of Molecular Design and Drug Discovery;Tianjin Institute of Pharmaceutical Research;
..............page:567-571
..............page:572-576
..............page:577-581
..............page:582-586
..............page:587-590
..............page:591-594
..............page:595-598
..............page:599-603
..............page:604-607
..............page:608-610
..............page:611-614
..............page:615-618
..............page:619-622
..............page:623-627
..............page:628-631
..............page:632-635
..............page:636-639
..............page:640-644
..............page:645-649
..............page:650-653
..............page:654-658
..............page:659-662
..............page:663-666
..............page:667-672
..............page:673-677
..............page:678-682
..............page:683-686
..............page:687-690
..............page:691-695
..............page:696-700
..............page:701-704
..............page:705-708
..............page:709-712
..............page:713-717
..............page:718-722
..............page:723-726
Research progress on lipid-regulating mechanism of berberine
JIANG Tian;JIA You-hong;LI Yi-shi;Center for Clinical Pharmacology;Key Laboratory of Clinical Trial Research in Cardiovascular Drugs Ministry of Health;Fuwai Hospital;National Center For Cardiovascular Disease;Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:727-730